Braftovi Encorafenib 50 mg Capsules

Braftovi (Encorafenib 50 mg Capsules) is a prescription medication used for the treatment of certain types of cancer. Encorafenib is a kinase inhibitor that targets and inhibits the activity of the BRAF V600E mutation, which plays a role in the growth and spread of cancer cells.

Indications:

Braftovi is indicated for the treatment of:

• BRAF V600E mutation-positive unresectable or metastatic melanoma, in combination with binimetinib.
• BRAF V600E mutation-positive metastatic colorectal cancer, in combination with cetuximab, after prior therapy.

How to Use:

• Take Braftovi exactly as prescribed by your healthcare provider.
• Swallow the capsule whole with a full glass of water.
• Do not crush, chew, or open the capsule.
• Braftovi should be taken either at least 1 hour before or 2 hours after a meal.
• Follow your doctor's instructions regarding dosage and duration of treatment.

Side Effects:

Common side effects of Braftovi may include:

• Fatigue
• Nausea
• Diarrhea
• Vomiting
• Abdominal pain
• Joint pain (arthralgia)
• Rash
• Hair loss

Precautions:

• Inform your healthcare provider about any existing medical conditions and medications you are taking.
• Regular monitoring may be required to manage side effects and ensure the effectiveness of the treatment.
• Use effective contraception to avoid pregnancy while taking Braftovi, as it may harm an unborn baby.
• Braftovi is not recommended for use in breastfeeding women.

Storage:

• Store Braftovi capsules at room temperature between 20°C to 25°C (68°F to 77°F).
• Keep the capsules in their original container, tightly closed and protected from light.
• Keep out of reach of children.

Disclaimer:

This product description is provided for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new medication.